You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ)連續6個漲停 新型冠狀病毒的檢測試劑盒預計2月中旬前可進入臨牀驗證
格隆匯 02-07 18:36

格隆匯2月7日丨陽普醫療(300030.SZ)公佈,公司股票於2020年2月5日、2020年2月6日、2020年2月7日連續三個交易日收盤價格漲幅偏離值累計超過20%,根據深圳證券交易所的有關規定,屬於股票交易異常波動的情況。

2020年春節前後,新型冠狀病毒肺炎疫情(2019-nCoV)迅速蔓延,給中國人民的生活和健康帶來極大威脅。疫情發生後,公司快速啟動緊急預案,在做好自身防控工作的同時,緊急召回員工恢復生產口罩、血液核酸檢測專用採血管、全自動採血管脱蓋機等疫情相關醫用物資,積極履行醫療行業企業的社會責任。

2020年2月4日,公司子公司陽普醫療(湖南)有限公司(“湖南陽普”)取得醫用外科口罩的醫療器械註冊證,湖南陽普取得該項產品註冊證書後,將具備向醫療機構供應N95級醫用外科口罩的資質。此外,湖南陽普醫用外科口罩的醫療器械生產許可證及另一款醫用防護口罩應急註冊工作仍在進行中,存在不確定性。敬請投資者給予關注並注意投資風險。

陽普醫療研發的新型冠狀病毒檢測試劑盒適用於杭州子公司康代思鋭生物科技公司自主研發的Q-velox平台,該檢測系統獨立、封閉、全自動、體積小,能夠快速為基層醫療機構提供標準化的檢測和診斷能力。目前,新型冠狀病毒的檢測試劑盒已經完成設計,預計2月中旬前可進入臨牀驗證。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account